Previous 10 | Next 10 |
Antares Pharma (NASDAQ: ATRS) is one of the fastest-growing biotech stocks in the sector, with multiple collaboration agreements with large-cap pharmaceutical companies to supply it with pressure-assisted injector devices. The wheel of fortune, however, has not been kind to Antares, as its ...
EWING, N.J., May 27, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 10:00 a.m. Eastern Time. A live webcast of...
Image source: The Motley Fool. Antares Pharma Inc (NASDAQ: ATRS) Q1 2020 Earnings Call May 5, 2020 , 8:30 a.m. ET Operator Continue reading
Antares Pharma, Inc. (ATRS) Q1 2020 Earnings Conference Call May 05, 2020, 08:30 ET Company Participants John Howarth - VP, Corporate Affairs Robert Apple - CEO, President & Director Fred Powell - EVP & CFO Conference Call Participants Kenneth Cacciatore - Cowen and...
After the company reported mixed first-quarter financial results that were better than expected on the top line and worse than expected on the bottom line, shares in Antares Pharma (NASDAQ: ATRS) had tumbled 12.3% at 12 p.m. EST on Tuesday. The healthcare company delivered robus...
The following slide deck was published by Antares Pharma, Inc. in conjunction with their 2020 Q1 earnings Read more ...
Hertz Global Holdings (NYSE: HTZ ) -16% after it enters into forbearances and limited waivers . More news on: Hertz Global Holdings, Inc., Centennial Resource Development, Inc., Compass Diversified Holdings LLC, Stocks on the move, , Read more ...
Antares Pharma ( ATRS ) Q1 results : More news on: Antares Pharma, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Antares Pharma (NASDAQ: ATRS ): Q1 GAAP EPS of -$0.01 misses by $0.01 . More news on: Antares Pharma, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
First Quarter 2020 Revenue $33.1 Million, a 42% Increase Compared to First Quarter 2019 Generated $5.6 Million in Cash from Operations during the First Quarter 2020 EWING, N.J., May 05, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company...
News, Short Squeeze, Breakout and More Instantly...
Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma PR Newswire SAN DIEGO , May 12, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (" Halozyme ") today announced that the waiting period unde...
Antares Pharma Inc shares ( NASDAQ: ATRS ) are up 45% on Wednesday after Halozyme Therapeutics said it will buy the New Jersey-headquartered company for $960 million in cash. Details of the agreement The deal translates to $5.60 per share for Antares Pharma shareholders that...